Skip to content

13F-HR filed by Foresite Capital Management V, LLC

Foresite Capital Management V, LLC filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-11, with 10 holding rows worth $136,901,888.

Accession
0001104659-23-090058
Filed
2023-08-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 10 entries on the cover page, a total value of $136,901,888 stated on the cover page (in dollars after the unit check, H1), rows summing to $136,901,888 with VALUE read as dollars as filed, 13F file number 028-20850. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
HIMS & HERS HEALTH INC433000106COM CL A3,733,381$35,093,781dollars as filed
THESEUS PHARMACEUTICALS INC88369M101COM3,585,346$33,451,278dollars as filed
PARDES BIOSCIENCES INC69945Q105COM10,811,887$19,569,515dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock1,258,243$13,047,980dollars as filed
DISC MEDICINE INC COM254604101Stock243,513$10,811,977dollars as filed
KINNATE BIOPHARMA INC49705R105COM3,525,957$10,683,650dollars as filed
SOMALOGIC INC83444K105COM3,403,276$7,861,568dollars as filed
COMPASS THERAPEUTICS INC20454B104COM1,324,071$4,210,546dollars as filed
QUANTUM SI INC74765K105COM CL A924,404$1,654,683dollars as filed
PHARVARIS NVN69605108COMMON STOCK34,142$516,910dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-23-090058this filing2023-08-11acceptance time not in the bulk data set